The BCG vaccine is built fairly differently from the Pfizer and Moderna Covid vaccines, which have been similarly effective against the virus. Instead of mRNA, ...

The BCG vaccine was first used against TB in the 1920's and then started to be used as the first cancer immunotherapy around ...

New global study shows childhood vaccine coverage stalled by COVID-19, with urgent need to boost immunisation by 2030 to meet WHO targets.

The treatment consists of instilling the BCG vaccine directly into the bladder. When the treatment works, the 15-year survival rate for patients with so-called “non-muscle-invasive” (early ...

Administering the Bacillus Calmette-Guérin (BCG) vaccine during the active phase of COVID-19 may help protect against the development of long COVID. A phase 3 clinical trial initiated in early ...

The Therapeutic BCG Vaccine Market offers growth opportunities through expanding applications beyond TB prevention, including bladder cancer and autoimmune diseases. Advances in biotechnology ...

Academic researchers in Massachusetts believe the standard BCG (bacillus Calmette-Guérin) vaccine could have a remarkable second use: a treatment to reverse advanced type 1 diabetes.

More than 6 million Americans currently live with Alzheimer's disease, a number predicted to rise as our population ages.

BCG vaccine—named for its developers—contains inactivated mycobacteria that infect cattle and remains the only vaccination strategy against the infection in humans.

BCG Vaccine Market Size and Forecast. According to analysts at Vantage Market Research, the global BCG (Bacillus Calmette-Guerin) Vaccine Market is projected to witness significant growth in the ...

Sam S. Chang MD, MBA, discusses intravesical mitomycin in low-grade intermediate-risk nonmuscle-invasive bladder cancer vs ...